Yimei Capital logo

Yimei Capital

Asia, Shanghai, China, Shanghai

Description

Yimei Capital is an investment Firm.

Investor Profile

Yimei Capital has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (50%)
  • Series C (50%)

Country Focus

  • United States (50%)
  • China (50%)

Industry Focus

  • Cloud Management
  • Machine Learning
  • Semiconductor
  • Big Data
  • Biotechnology
  • Health Care
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Yimei Capital frequently co-invest with?

Co-Investments: 1
Susquehanna International Group (SIG)
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 1
DUMAC
North America, North Carolina, United States, Durham
Co-Investments: 1
Majuven
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Acorn Pacific Ventures
North America, California, United States, Santa Clara
Co-Investments: 1
Legend Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Softbank China & India Holdings
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
A
North America, California, United States, Santa Clara
Co-Investments: 1
CTC Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
SBCVC
Asia, Shanghai, China, Shanghai
Co-Investments: 2

What are some of recent deals done by Yimei Capital?

Corigine

Santa Clara, California, United States

Corigine delivers innovative solutions in connectivity, storage, and machine learning for cloud, automotive, and emerging applications.

Cloud ManagementMachine LearningSemiconductor
SeedMar 22, 2021
Amount Raised: $10,000,000
New Horizon Health

Hangzhou, Zhejiang, China

New Horizon Health is a bio-tech company focusing on early screening and genetic testing services for high-incidence cancer homes.

Big DataBiotechnologyHealth CareMedical
Series CMay 24, 2019
Amount Raised: $66,500,000